نمایش پرونده ساده آیتم

dc.contributor.advisorMirghafourvand, Mojgan
dc.contributor.advisorRezaei, Mansour
dc.contributor.authorShoorshi, Fatemeh
dc.date.accessioned2025-05-06T06:03:04Z
dc.date.available2025-05-06T06:03:04Z
dc.date.issued2024en_US
dc.identifier.urihttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/72359
dc.description.abstractAbstract Background: Pain is a risk factor for postpartum depression. This study aimed to determine the relationship between remifentanil analgesia and postpartum depression, as well as the birth experience in Iranian women. Materials and Methods: This prospective cohort study was conducted on 200 mothers who underwent vaginal birth at Taleghani Hospital in Tabriz, Iran, in 2023-2024. The Edinburgh Postnatal Depression Scale and the Childbirth Experience Questionnaire were used to assess the outcomes. To compare the childbirth experience and postpartum depression between the exposure group (receiving remifentanil) and the non-exposure group, independent t-tests, and Mann-Whitney U tests were employed, respectively. Results: The mean postpartum depression score in the remifentanil analgesia group was statistically significantly lower than in the non-analgesia group (p= 0.002). The mean total childbirth experience score in the exposure group was statistically significantly higher than in the non-exposure group (p< 0.001). Additionally, a comparison of the subdomains of childbirth experience between the two groups revealed that the mean scores for own capacity (p< 0.001), perceived safety (p< 0.001), and participation (p< 0.001) were statistically significantly higher in the remifentanil group compared to the non-analgesia group. However, there was no statistically significant difference between the two groups regarding the professional support subdomain (p= 0.434). Based on the Spearman test, no statistically significant correlation was found between childbirth experience and postpartum depression in either the remifentanil analgesia or non-analgesia groups (p> 0.05). Conclusion: These findings highlight the importance of using remifentanil analgesia as a potential option for preventing postpartum depression and creating a positive childbirth experience. It is recommended that clinical trials be conducted to obtain more precise findings.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, School of Nursing and Midwiferyen_US
dc.relation.isversionofhttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/72358en_US
dc.subjectKeywords: Postpartum, analgesia, satisfaction with childbirth, remifentanil, postpartum depressionen_US
dc.titleDetermining the relationship between remifentanil analgesia and postpartum depression and childbirth experience in women referred to Taleghani Educational and Medical Center, Tabrizen_US
dc.typeThesisen_US
dc.contributor.supervisorMalakouti, Jamileh
dc.contributor.supervisorGhanbari Homayi, Solmaz
dc.identifier.docnoپ1155en_US
dc.identifier.callno1155en_US
dc.contributor.departmentNursing Educationen_US
dc.description.disciplinenursingen_US
dc.description.degreeMaster of nursingen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم